Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes

Eunyoung Park1,2, Shaun Rawson2, Kunhua Li1,2

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Nature
|October 4, 2019
PubMed

Insights

Structural insights reveal how 14-3-3 proteins regulate BRAF kinase activity. These findings explain BRAF

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • RAF kinases, including BRAF, are key regulators of the MAP kinase cascade controlling cell growth.
  • Dysregulated RAF activity is implicated in various cancers, yet its structural regulation remains unclear.
  • Understanding BRAF regulation is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the structural mechanisms underlying BRAF kinase autoinhibition and activation.
  • To investigate the role of 14-3-3 proteins in BRAF regulation.
  • To provide a structural basis for understanding BRAF mutations in cancer.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) was employed to determine high-resolution structures.
  • Structures of full-length BRAF were solved in complex with MEK1 and 14-3-3 dimers.
  • Analysis focused on autoinhibited and active states of BRAF.

Main Results:

  • An autoinhibited BRAF-MEK1 complex is stabilized by a 14-3-3 dimer binding to phosphorylated BRAF sites.
  • 14-3-3 binding sequesters key BRAF domains, preventing kinase dimerization and activity.
  • Activation involves 14-3-3 mediating the formation of an active, dimeric BRAF kinase.

Conclusions:

  • The 14-3-3 dimer acts as a crucial scaffold, controlling BRAF kinase autoinhibition and activation.
  • These structural findings offer insights into BRAF regulation and its aberrant function in disease.
  • The study provides a framework for understanding BRAF-related cancers and developmental disorders.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.4K